BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2657403)

  • 1. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.
    Coppola JA; Parker JM; Schuler GD; Cole MD
    Mol Cell Biol; 1989 Apr; 9(4):1714-20. PubMed ID: 2657403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells.
    Prochownik EV; Kukowska J; Rodgers C
    Mol Cell Biol; 1988 Sep; 8(9):3683-95. PubMed ID: 2464742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A balance between self-renewal and commitment in the murine erythroleukemia cells with the transferred c-myc gene; an in vitro stochastic model.
    Yamamoto T; Masuko K; Takada S; Kume TU; Obinata M
    Cell Differ Dev; 1989 Nov; 28(2):129-33. PubMed ID: 2692787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation.
    Todokoro K; Ikawa Y
    Biochem Biophys Res Commun; 1986 Mar; 135(3):1112-8. PubMed ID: 3457564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
    Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
    Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myb but not c-myc suppresses the hemin-induced nonterminal expression of hemoglobin by murine erythroleukemia cells.
    Prochownik EV
    Blood; 1989 Feb; 73(3):782-6. PubMed ID: 2644989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
    J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
    Kohlhuber F; Strobl LJ; Eick D
    Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myb effects on kinetic events during MEL cell differentiation.
    Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
    Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
    Sasaki H; Watanabe T; Nomura S; Oishi M
    Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells.
    Spotts GD; Hann SR
    Mol Cell Biol; 1990 Aug; 10(8):3952-64. PubMed ID: 2196440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-myc protooncogene expression in mouse erythroleukemia cells.
    Lachman HM
    Environ Health Perspect; 1989 Mar; 80():161-72. PubMed ID: 2647476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transformed cells to terminal differentiation.
    Marks PA; Sheffery M; Ramsay R; Ikeda K; Rifkind RA
    Ann N Y Acad Sci; 1987; 511():246-55. PubMed ID: 3326466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiazofurin induction of mouse erythroleukemia cell hemoglobin production in the absence of commitment or changes in protooncogene expression.
    Sherman ML; Shafman TD; Colman MS; Kufe DW
    Blood; 1989 Feb; 73(2):431-4. PubMed ID: 2917182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the c-myb and c-myc genes is regulated independently in differentiating mouse erythroleukemia cells by common processes of premature transcription arrest and increased mRNA turnover.
    Watson RJ
    Mol Cell Biol; 1988 Sep; 8(9):3938-42. PubMed ID: 2851731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early protooncogene expression during hemin-induced differentiation of human erythroleukemic cells.
    Griffin MO; Nelson JC; Abraham NG
    Leuk Res; 1990; 14(11-12):997-1006. PubMed ID: 2280614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.